Question · asked by 1 review
All doses of cerivastatin vs placebo: Withdrawals due to adverse events
- Population
- participants with normal or abnormal lipid profiles
- Intervention
- All doses of cerivastatin
- Comparison
- placebo
- Outcome
- Withdrawals due to adverse events
It is very uncertain whether all doses of cerivastatin changes withdrawals due to adverse events compared with placebo (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
All doses of cerivastatin vs placebo Withdrawals due to adverse events · participants with normal or abnormal lipid profiles It is very uncertain whether all doses of cerivastatin changes withdrawals due to adverse events compared with placebo (very low certainty). Cerivastatin for lowering lipids (2020) · Cochrane Headline outcomes only | RR 1.09 [0.68, 1.74] | 11 studies · 6570 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Cerivastatin for lowering lipids 2020 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.